Lyn Rees - Novacyt CEO Director
| ALNOV Stock | EUR 0.41 0.01 2.38% |
CEO
Lyn Rees is CEO Director of Novacyt
| Age | 53 |
| Address | 131 Boulevard Carnot, Le Vésinet, France, 78110 |
| Phone | 33 1 39 46 51 04 |
| Web | https://www.novacyt.com |
Novacyt Management Efficiency
The company has return on total asset (ROA) of (0.111) % which means that it has lost $0.111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5122) %, meaning that it generated substantial loss on money invested by shareholders. Novacyt's management efficiency ratios could be used to measure how well Novacyt manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/06/2026, Return On Tangible Assets is likely to drop to -0.78. In addition to that, Return On Capital Employed is likely to grow to -0.5. At this time, Novacyt's Total Current Liabilities is relatively stable compared to the past year. As of 02/06/2026, Non Current Liabilities Total is likely to grow to about 20 M, while Liabilities And Stockholders Equity is likely to drop slightly above 72 M.Similar Executives
| Found 7 records | CEO Age | ||
| Ludovic Lastennet | Implanet SA | N/A | |
| Martin Deterre | Theradiag SA | N/A | |
| Mario Crovetto | Ikonisys SA | 72 | |
| Laurent Cassedanne | Advicenne | 58 | |
| Nicolas Trouche | Poxel SA | N/A | |
| Alexandre Loiseau | Mauna Kea Technologies | N/A | |
| Gavin Spencer | NicOx SA | 57 | |
Management Performance
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.11 |
Novacyt Leadership Team
Elected by the shareholders, the Novacyt's board of directors comprises two types of representatives: Novacyt inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novacyt. The board's role is to monitor Novacyt's management team and ensure that shareholders' interests are well served. Novacyt's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novacyt's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Coyne, Chief Officer | ||
| Wendy Cox, Director HR | ||
| Steve Gibson, Member of the Executive Team, Group Financial Controller | ||
| David Franks, Chief Officer | ||
| Grald Ulrich, Chief Devel | ||
| Lyn Rees, CEO Director | ||
| James McCarthy, Acting CFO | ||
| Joanne Mason, Chief Director | ||
| Wendy Karban, Member of the Executive Team, Group Human Resource Manager | ||
| Bryan Close, Chief Officer | ||
| Paul Oladimeji, Group RD |
Novacyt Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Novacyt a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (1.56) % | ||||
| Operating Margin | (0.65) % | ||||
| Current Valuation | 13.8 M | ||||
| Shares Outstanding | 70.63 M | ||||
| Shares Owned By Insiders | 0.06 % | ||||
| Price To Earning | (1.71) X | ||||
| Price To Book | 0.60 X | ||||
| Price To Sales | 1.48 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Novacyt Stock Analysis
When running Novacyt's price analysis, check to measure Novacyt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novacyt is operating at the current time. Most of Novacyt's value examination focuses on studying past and present price action to predict the probability of Novacyt's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novacyt's price. Additionally, you may evaluate how the addition of Novacyt to your portfolios can decrease your overall portfolio volatility.